Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays

PLoS ONE(2020)10.1371/journal.pone.0237828Source: DataRank Database

Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 95 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access95 citations

Download PDF

Cite:

Linked data & code

gen nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 2.26)OA: goldTopics (87)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Saman Saadat ORCID,Ebtehal Saleh,Xin Ouyang ORCID,Niel T. Constantine,Anthony L. DeVico

Live enrichment

PubMed:33137138 PMC:PMC7605638 OpenAlex:https://openalex.org/W3094898198

National Institute of Allergy and Infectious Diseases

Grant: R01AI147870-01A1

U.S. Department of Veterans Affairs

Grant: IBX004525-01A2 and IBX005469A

Centers for Disease Control and Prevention

Grant: U01CK000556-02-01

BLRD VA

Grant: I01 BX005469

BLRD VA

Grant: I01 BX004525

NIAID NIH HHS

Grant: P01 AI124912

NIAID NIH HHS

Grant: R01 AI147870

NCEZID CDC HHS

Grant: U01 CK000556

National Institutes of Health

Grant: 5R01AI147870-04

Engineering of pan-neutralizing anti-HIV envelope antibodies

National Institutes of Health

Grant: 5U01CK000556-02

Epicenters for the Prevention of Healthcare-Associated Infections (HAIs); Cycle II Multicenter Program Studies

FWCI

2.26

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0237828&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0237828&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0237828

journalhttps://doi.org/10.1371/journal.pone.0237828

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33137138

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingMonoclonal and Polyclonal Antibodies Research03 medical and health sciences0303 health sciencesAdultAgedAged, 80 and overAntibodies, ViralArea Under CurveBetacoronavirusCOVID-19Coronavirus InfectionsFemaleHumansImmunoassayImmunoglobulin AImmunoglobulin GImmunoglobulin MMaleMiddle AgedNucleocapsidPandemicsPneumonia, ViralROC CurveReproducibility of ResultsSARS-CoV-2Spike Glycoprotein, Coronavirus

MeSH Terms

BetacoronavirusCOVID-19SARS-CoV-2AdultAgedAged, 80 and overAntibodies, ViralFemaleHumansImmunoglobulin AImmunoglobulin GImmunoglobulin MImmunoassayMaleMiddle AgedPneumonia, ViralROC CurveReproducibility of ResultsCoronavirus InfectionsNucleocapsidArea Under CurvePandemicsSpike Glycoprotein, Coronavirus

Keywords

SerologyVirologyAntibodyCoronavirusImmunoglobulin MImmunoglobulin GAntigenSpike ProteinSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)MedicineImmunologyBiologyPathologyAdultMaleSciencePneumonia, ViralAntibodies, ViralBetacoronavirusHumansNucleocapsidPandemicsAgedAged, 80 and overImmunoassayQRCOVID-19Middle AgedImmunoglobulin AROC CurveArea Under CurveFemaleCoronavirus InfectionsResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being